Purity specifications, storage, and distribution for medications development contract
Active Definitive Contract Awarded Last action
- Contract number
- 75N95022C00014
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,842,135
Award facts
- Opportunity
-
- Purity Specifications, Storage and Distribution for Medications Development Pre-Solicitation · N01DA228961 · Posted Oct 29, 2021
- Contract value 100% obligated
- $2,842,134.75 Current and potential, with all options
- Completion date 86% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$57,437 | |
| Exercise an Option | $490,080 | |
| Change Order | $523,817 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $644,104 | |
| Exercise an Option | $614,271 | |
| Exercise an Option | $2,807 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $168,566 | |
| Original award | $455,927 |
About this award
The National Institute on Drug Abuse awarded a definitive contract to Research Triangle Institute for purity specifications, storage, and distribution of medications in support of drug compound research on July 9, 2022, with a ceiling value of $2,842,134.75 and a performance period through July 8, 2027.
The originating solicitation called for establishing a centralized repository to receive, store, analyze, and distribute approximately 10,000 drug compounds from domestic and international sources to support NIDA and other NIH Institutes. The solicitation required demonstrated capability in analytical testing (TLC, HPLC, MS, GC, NMR), domestic and international blinded-sample shipping, database management, and Controlled Substances Act registration for Schedules I through V. Place of performance is Durham, NC. The contract carries cost-plus-no-fee pricing with no set-aside.
Under this contract, Research Triangle Institute invoiced $645 thousand across FY2022–FY2024, with the most recent fiscal year (FY2024) reflecting 1.0 FTEs and 2,104 contractor hours at a derived government-paid rate of $15.95 per hour. The labor footprint declined year-over-year; FY2023 represented peak activity at $544 thousand invoiced across 2,121 hours. The prime self-performed all reported labor during FY2024. Subcontractors on record include Cayman Chemical Co Inc. and Medchemexpress LLC, both supplying specialized chemical compounds and analytical support.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Cayman Chemical Co Inc. | $38,044 | |
| Medchemexpress LLC | $46,535 | |
| Medchemexpress LLC | $46,535 |
Quick answers
Who was awarded contract 75N95022C00014?
75N95022C00014 was awarded to Research Triangle Institute by National Institute on Drug Abuse (National Institutes of Health) on July 9, 2022.
How much is contract 75N95022C00014 worth?
The government has obligated $2,842,135 on 75N95022C00014.
Was contract 75N95022C00014 competed?
The extent of competition for 75N95022C00014 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award